# Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis

Study · id `cardio:ct-nct03201432` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03201432](<https://clinicaltrials.gov/study/NCT03201432>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03201432

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

## Technical summary

Registry record NCT03201432. Randomized; no masking; primary purpose treatment. Start 2014-05 (registry gives no type); primary completion 2017-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 160 participants (enrolled count; ClinicalTrials.gov record NCT03201432, source copy `cardio:ctgov-nct03201432-2017-06-28`, retrieved 2026-10-26)
- Start date: 2014-05 (registry gives no type) (ClinicalTrials.gov record NCT03201432, source copy `cardio:ctgov-nct03201432-2017-06-28`, retrieved 2026-10-26)
- Primary completion: 2017-01 (actual) (ClinicalTrials.gov record NCT03201432, source copy `cardio:ctgov-nct03201432-2017-06-28`, retrieved 2026-10-26)
- Completion: 2017-01 (actual) (ClinicalTrials.gov record NCT03201432, source copy `cardio:ctgov-nct03201432-2017-06-28`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03201432-2017-06-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis
- Condition: Ischemic Stroke
- Condition: Vertebral Artery Stenosis
- Intervention (Device): Drug eluting stent (DES)
- Intervention (Device): Bare metal stent (BES)
- Lead sponsor: Xiongjing Jiang
- Lead sponsor class: OTHER
- Collaborator: Yinyi(Liaoning) Biotech Co., Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: b67ce9921fb1891478338345dc850d54486c2de02110b58bb8531fc1d8e0f753
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
